Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17250
Corporate User License Price USD 750
Corporate User License Price INR 51750
Site License Price USD 500
Site License Price INR 34500
Request a Quote

Report Title

German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

German Cancer Research Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute's research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and prevention, structural and functional genomics, infection and cancer, and tumor immunology. Its services include medical services, technical services, press and public relations, technology transfer, cancer prevention, research works, training among others. DKFZ concentrates on the transfer of approaches in the prevention, diagnosis and treatment of cancer to clinical application. The institute operates through its facilities including centre for preclinical research, genomics and proteomics, imaging and cytometry, information technology, library, animal laboratory services and chemical biology. DKFZ is headquartered in Heidelberg, Germany.

German Cancer Research Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

German Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

German Cancer Research Center, Medical Devices Deals, 2012 to YTD 2018 10

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

German Cancer Research Center, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Apogenix Secures USD 9.8 Million In Venture Financing 12

Partnerships 13

Cyclenium Pharma Enters into Agreement with German Cancer Research Centre 13

ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 14

Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center For Cancer Therapies 15

Genetic Immunity Enters Into Agreement With German Cancer Research Center To Develop HPV Therapeutic Vaccine 16

Licensing Agreements 17

Imaxio Enters into License Agreement with German Cancer Research 17

Sciomics Enters into Licensing Agreement with German Cancer Research Center 18

German Cancer Research Center-Key Competitors 19

German Cancer Research Center-Key Employees 20

German Cancer Research Center-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Joint Venture 21

Recent Developments 22

Government and Public Interest 22

Sep 07, 2018: International collaboration brings USD 9.6 million grant to Colorado 22

Aug 01, 2018: Cancer drug-in a different way than expected 23

Jul 09, 2018: Brain cancer: Typical mutation in cancer cells stifles immune response 24

Jun 26, 2018: New therapy makes blood cancer cells visible for the immune system 25

Jun 26, 2018: New technique makes blood cancer cells visible for the immune system 26

Jun 12, 2018: Malaria: Cooperating antibodies enhance immune response 27

Feb 27, 2018: Colorectal cancer: Combined analysis enhances risk prediction 28

Feb 14, 2018: European excellence grant for DKFZ researcher 29

Jan 29, 2018: Kristian Pajtler received USD 100,000 award for brain cancer research 30

Jan 18, 2018: Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy 31

Jan 15, 2018: New research project on age-related diseases 32

Jan 10, 2018: Genetic defect makes malignant smooth muscle tumors vulnerable 33

Nov 08, 2017: Misregulated protein breakdown promotes leukemias and brain cancer 34

Nov 06, 2017: Rare pancreatic cancer reveals targets for therapy 35

Aug 23, 2017: Chaos in cell division-How chromosomal defects arise in cancer cells 36

Aug 02, 2017: Therapies for Older Leukemia Patients 37

Jun 30, 2017: EUR5.7 Million for Novel Treatment Approaches in Pediatric Brain Cancer 38

Jun 28, 2017: Improving Outcomes Through Personalized Medicine 39

Jun 12, 2017: Mysterious gene transcripts after cancer therapy 40

May 29, 2017: Macrophages control the development of nerves and blood vessels in the brain 41

May 02, 2017: Tailor-made viruses for enhanced cancer therapy 42

Apr 10, 2017: Human blood cells develop in a continuous process instead of a stepwise one 43

Apr 07, 2017: European million grants for three DKFZ researchers 44

Apr 03, 2017: Antibody is effective against radiation-induced pulmonary fibrosis 45

Jan 03, 2017: DKFZ-researcher receives ERC-Grant 46

Other Significant Developments 47

Sep 11, 2018: New approach uncovers tumor promoting signaling pathway in common children's brain tumor 47

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

German Cancer Research Center, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

German Cancer Research Center, Pharmaceuticals & Healthcare, Key Facts 2

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

German Cancer Research Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

German Cancer Research Center, Deals By Therapy Area, 2012 to YTD 2018 9

German Cancer Research Center, Medical Devices Deals, 2012 to YTD 2018 10

German Cancer Research Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Apogenix Secures USD 9.8 Million In Venture Financing 12

Cyclenium Pharma Enters into Agreement with German Cancer Research Centre 13

ValiRx Enters into Agreement with German Cancer Research Center for VAL-101 14

Bayer HealthCare Extends Co-Development Agreement With German Cancer Research Center For Cancer Therapies 15

Genetic Immunity Enters Into Agreement With German Cancer Research Center To Develop HPV Therapeutic Vaccine 16

Imaxio Enters into License Agreement with German Cancer Research 17

Sciomics Enters into Licensing Agreement with German Cancer Research Center 18

German Cancer Research Center, Key Competitors 19

German Cancer Research Center, Key Employees 20

German Cancer Research Center, Subsidiaries 21

German Cancer Research Center, Joint Venture 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

German Cancer Research Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person